Aurobindo Pharma gets USFDA nod to launch anti-diabetic drug in US – Times of India

Currently, Aurobindo’s other banned unit VI, which makes cephalosporin based drugs, is awaiting the clearance from USFDA. With the approval of metformin hydrochloride, Aurobindo Pharma now has a total of 153 ANDA (abbreviated new drug …